The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease
- 1 October 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (7) , 1752-1762
Abstract
P2X7 receptor (P2X7R) is highly expressed on immune cells, triggering the release of cytokines and regulating autoimmune responses. To investigate P2X7R surface expression on T helper (Th) 1, Th17, and regulatory T (Treg) cells in patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) and correlations with disease activity, 29 SLE and 29 RA patients and 18 healthy controls (HCs) were enrolled. We showed that SLE and RA patients had significantly higher levels of plasma cytokines (IFN-γ, IL-1β, IL-6, IL-17A, and IL-23), frequencies of Th1 and Th17 cells, and expression of P2X7R on Th1 and Th17 than HCs, and the Th17/Treg ratio was significantly increased, whereas Treg cell levels were significantly decreased. The Ca2+ influx increase following BzATP stimulation was significantly higher in CD4+PBMCs from SLE and RA patients than in HCs. Blood levels of shed P2X7R were increased in SLE and RA patients. Furthermore, 28-joint Disease Activity Score and SLE Disease Activity Index score showed negative correlations with Treg cell levels and positive correlations with Th17/Treg ratio and Th17 cell P2X7R expression. Interestingly, Th17 cell P2X7R expression was closely correlated with IL-1β, C-reactive protein, the erythrocyte sedimentation rate, anticyclic citrullinated peptide Abs, albumin, and C4. These data indicate that increased Th17 cell P2X7R expression is functionally and positively related to disease activity and some inflammatory mediators in SLE and RA patients, and P2X7R could be critical in promoting the Th17 immune response and contributing to the complex pathogenesis of SLE and RA. Key Points P2X7R expression on Th subsets is changed in RA and SLE patients. Th17 cell P2X7R expression is positively related to DAS28 and SLEDAI scores. Highly expressed P2X7R on CD4+ PBMCs is functional in RA and SLE patients.Keywords
Funding Information
- National Natural Science Foundation of China (81770915, 81301737)
- Major Program of Shandong Province Natural Science Foundation (ZR2018ZC1054)
This publication has 53 references indexed in Scilit:
- The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndromeJournal of Internal Medicine, 2013
- Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of PsoriasisThe Journal of Immunology, 2013
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X ReceptorsScience Signaling, 2011
- Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosusRheumatology International, 2010
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Expression and function of the P2X7 purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritisHuman Immunology, 2010
- P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosusTissue Antigens, 2008
- Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritisClinical and Experimental Immunology, 2008
- Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritisNephrology Dialysis Transplantation, 2006